alto ingredients - ALTO

ALTO

Close Chg Chg %
1.45 -0.01 -0.69%

Pre-Market

1.44

-0.01 (0.69%)

Volume: 896.30K

Last Updated:

Dec 3, 2024, 4:00 PM EDT

Company Overview: alto ingredients - ALTO

ALTO Key Data

Open

$1.43

Day Range

1.41 - 1.45

52 Week Range

1.18 - 3.00

Market Cap

$110.37M

Shares Outstanding

76.65M

Public Float

72.71M

Beta

1.92

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.51

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.34M

 

ALTO Performance

1 Week
 
-0.69%
 
1 Month
 
10.77%
 
3 Months
 
0.70%
 
1 Year
 
-45.25%
 
5 Years
 
206.38%
 

ALTO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About alto ingredients - ALTO

Alto Ingredients, Inc. engages in the production and marketing of specialty alcohols and essential ingredients. It operates through the following segments: Marketing and Distribution, Pekin Production, and Western Production. The Marketing and Distribution segment includes marketing and merchant trading for company-produced alcohols and essential ingredients, on an aggregated basis, and third-party fuel-grade ethanol. The Pekin Campus Production segment deals with the production and sale of alcohols and essential ingredients produced at the company's Pekin, Illinois campus. The Western Production segment covers the production and sale of renewable fuel and essential ingredients produced at two western production facilities. The company was founded by William L. Jones and Neil M. Koehler on January 30, 2003, and is headquartered in Pekin, IL.

ALTO At a Glance

Alto Ingredients, Inc.
1300 South Second Street
Pekin, Illinois 61554
Phone 1-916-403-2123 Revenue 1.22B
Industry Chemicals: Specialty Net Income -28,005,000.00
Sector Process Industries Employees 460
Fiscal Year-end 12 / 2024
View SEC Filings

ALTO Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.16
Price to Book Ratio 0.72
Price to Cash Flow Ratio 8.857
Enterprise Value to EBITDA 18.09
Enterprise Value to Sales 0.209
Total Debt to Enterprise Value 0.413

ALTO Efficiency

Revenue/Employee 2,658,565.217
Income Per Employee -60,880.435
Receivables Turnover 20.823
Total Asset Turnover 2.573

ALTO Liquidity

Current Ratio 2.585
Quick Ratio 1.779
Cash Ratio 0.697

ALTO Profitability

Gross Margin 1.937
Operating Margin -0.734
Pretax Margin -2.282
Net Margin -2.29
Return on Assets -5.893
Return on Equity -9.531
Return on Total Capital -7.274
Return on Invested Capital -7.253

ALTO Capital Structure

Total Debt to Total Equity 37.724
Total Debt to Total Capital 27.391
Total Debt to Total Assets 22.782
Long-Term Debt to Equity 36.174
Long-Term Debt to Total Capital 26.265
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Alto Ingredients - ALTO

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
897.02M 1.21B 1.34B 1.22B
Sales Growth
-37.05% +34.66% +10.57% -8.44%
Cost of Goods Sold (COGS) incl D&A
858.94M 1.16B 1.38B 1.20B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
30.27M 23.29M 25.09M 23.08M
Depreciation
30.27M 23.29M 24.53M 22.49M
Amortization of Intangibles
- - 567.00K 588.00K
-
COGS Growth
-40.16% +35.25% +19.00% -13.25%
Gross Income
38.08M 46.17M (46.81M) 23.68M
Gross Income Growth
+462.90% +21.23% -201.40% +150.59%
Gross Profit Margin
+4.25% +3.82% -3.50% +1.94%
2020 2021 2022 2023 5-year trend
SG&A Expense
31.98M 29.18M 31.58M 32.66M
Research & Development
- - - -
-
Other SG&A
31.98M 29.18M 31.58M 32.66M
SGA Growth
-9.80% -8.74% +8.20% +3.44%
Other Operating Expense
- - - -
-
Unusual Expense
9.89M 4.24M 4.02M 16.22M
EBIT after Unusual Expense
(3.79M) 12.74M (82.41M) (25.20M)
Non Operating Income/Expense
4.43M 38.40M 44.56M 4.72M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
17.94M 3.59M 1.83M 7.42M
Interest Expense Growth
-11.20% -80.01% -49.07% +306.40%
Gross Interest Expense
17.94M 3.59M 1.83M 7.42M
Interest Capitalized
- - - -
-
Pretax Income
(17.30M) 47.55M (39.67M) (27.91M)
Pretax Income Growth
+82.92% +374.88% -183.43% +29.65%
Pretax Margin
-1.93% +3.94% -2.97% -2.28%
Income Tax
(17.00K) 1.47M 1.93M 97.00K
Income Tax - Current - Domestic
- 1.47M 1.93M 97.00K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - (17.00K)
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (600.00K)
-
Consolidated Net Income
(17.28M) 45.48M (41.60M) (28.00M)
Minority Interest Expense
- - - (2.17M)
-
Net Income
(15.12M) 45.48M (41.60M) (28.00M)
Net Income Growth
+83.01% +400.89% -191.46% +32.68%
Net Margin Growth
-1.69% +3.77% -3.11% -2.29%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(15.12M) 45.48M (41.60M) (28.00M)
Preferred Dividends
1.27M 1.26M 1.26M 1.26M
Net Income Available to Common
(16.38M) 44.22M (42.86M) (29.27M)
EPS (Basic)
-0.2796 0.6219 -0.5958 -0.3991
EPS (Basic) Growth
+85.31% +322.42% -195.80% +33.01%
Basic Shares Outstanding
58.61M 71.10M 71.94M 73.34M
EPS (Diluted)
-0.2796 0.6123 -0.5958 -0.3991
EPS (Diluted) Growth
+85.31% +318.99% -197.31% +33.01%
Diluted Shares Outstanding
58.61M 72.22M 71.94M 73.34M
EBITDA
36.37M 40.27M (53.30M) 14.10M
EBITDA Growth
+1,752.62% +10.74% -232.34% +126.46%
EBITDA Margin
+4.05% +3.33% -3.99% +1.15%

Snapshot

Average Recommendation BUY Average Target Price 4.50
Number of Ratings 2 Current Quarters Estimate -0.105
FY Report Date 12 / 2024 Current Year's Estimate -0.355
Last Quarter’s Earnings -0.04 Median PE on CY Estimate N/A
Year Ago Earnings -0.40 Next Fiscal Year Estimate 0.215
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 1 2 2
Mean Estimate -0.11 -0.02 -0.36 0.22
High Estimates -0.10 -0.02 -0.35 0.36
Low Estimate -0.11 -0.02 -0.36 0.07
Coefficient of Variance -6.73 N/A -1.99 95.38

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Alto Ingredients - ALTO

Date Name Shares Transaction Value
Jun 25, 2024 Douglas L. Kieta Director 315,828 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 25, 2024 Michael D. Kandris Director 666,264 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.28 per share 852,817.92
Jun 25, 2024 Gilbert E. Nathan Director 675,575 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 25, 2024 Dianne S. Nury Director 180,744 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 25, 2024 Maria G. Gray Director 118,958 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2024 Bryon T. McGregor President & CEO 797,265 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.29 per share 1,825,736.85
Apr 4, 2024 Auste Maria Graham Gen. Counsel, VP & Secy 230,124 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.29 per share 526,983.96
Apr 4, 2024 Robert R. Olander Chief Financial Officer 217,706 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.29 per share 498,546.74
Apr 4, 2024 Todd E. Benton Chief Operating Officer 133,612 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.29 per share 305,971.48

Alto Ingredients in the News